<DOC>
	<DOCNO>NCT01239004</DOCNO>
	<brief_summary>The present study ass low-density lipoprotein cholesterol ( LDL-C ) lower effect colesevelam adjunct niacin improvement lipid glycemic control dyslipidemic subject impair fast glucose .</brief_summary>
	<brief_title>Colesevelam Treatment Impaired Fasting Glucose During Niacin Therapy</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Colesevelam Hydrochloride</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>1 . Men woman ≥ 18 year age . 2 . NonHDLC ≥100 mg/dL ≤220 mg/dL Visits 1 2 . 3 . FPG ≥90 mg/dL ≤145 mg/dL , Visits 1 2 . 4 . HDLC &lt; 60 mg/dL Visits 1 2 , regardless gender . 5 . Untreated dyslipidemia , statin treatment equipotency atorvastatin ≤40 mg daily least 12 week prior Screening Visit 1 without change initiation prior randomization 1 . Known intolerance niacin bile acidsequestering drug aspirin . 2 . Any contraindication study medication ( niacin , aspirin colesevelam ) . 3 . History dysphagia , swallow disorder intestinal motility disorder . 4 . History pancreatitis . 5 . Fasting TG &gt; 500 mg/dL Visits 1 2 6 . Currently take medication diabetes mellitus , Type 1 2 , currently take glucoselowering drug ( e.g . metformin ) indication . 7 . Currently take drug may affect glycemic and/or lipid control ( e.g. , betablockers , etc . ) start within 12 week prior Visit 1 , prior randomization . This apply dietary supplements. ) . 8 . Body mass index ( BMI ) &gt; 40 kg/m2 . 9 . History acute myocardial infarction , unstable angina , transient ischemic attack , stroke revascularization procedure within 3 month prior Visit 1 prior randomization . 10 . Use prescription strength niacin , bile acid sequestrants , fibrates omega3 fatty acid within 8 week prior Visit 1 prior randomization . This apply dietary supplement . 11 . Unwilling abstain , study , weightloss drug ( include overthecounter ) weightloss program study . 12 . Current use , intend use study , cyclic hormone ( e.g. , oral vaginal contraceptive estrogen replacement therapy ) . 13 . Females pregnant , plan pregnant study period , lactate , woman childbearing potential use acceptable method contraception . Acceptable method include intrauterine device , cervical diaphragm plus spermicide , female condom plus spermicide , partner 's use condom plus spermicide . Partner 's vasectomy use condom spermicide consider acceptable form birth control . 14 . Current use , intend use study cyclosporine . 15 . Recent history ( past 12 month ) illicit drug use excessive ethanol use . Excessive ethanol use define &gt; 14 drink per week ( 1 drink = 12 oz beer , 5 oz wine , 1.5 oz hard liquor ) . 16 . Exposure investigational agent within 30 day prior Visit 1 , prior randomization . 17 . Individual condition Investigator believe would interfere ability provide inform consent , comply study instruction , might confound interpretation study result put subject undue risk .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>dyslipidemia</keyword>
	<keyword>hyperlipidemia</keyword>
	<keyword>hyperglycemia</keyword>
	<keyword>impaired fasting glucose</keyword>
</DOC>